Multi-site retrospective analysis of diffusion and perfusion magnetic resonance imaging correlates to glioma characteristics derived from radio-pathomic maps.

IF 13.4 1区 医学 Q1 CLINICAL NEUROLOGY
Samuel A Bobholz, Daniel Aaronsen, Aleksandra Winiarz, Savannah R Duenweg, Allison K Lowman, Michael Flatley, Fitzgerald Kyereme, Jennifer Connelly, E Kelly S Mrachek, Max O Krucoff, Anjishnu Banerjee, Peter S LaViolette
{"title":"Multi-site retrospective analysis of diffusion and perfusion magnetic resonance imaging correlates to glioma characteristics derived from radio-pathomic maps.","authors":"Samuel A Bobholz, Daniel Aaronsen, Aleksandra Winiarz, Savannah R Duenweg, Allison K Lowman, Michael Flatley, Fitzgerald Kyereme, Jennifer Connelly, E Kelly S Mrachek, Max O Krucoff, Anjishnu Banerjee, Peter S LaViolette","doi":"10.1093/neuonc/noaf044","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study determines the relationship between diffusion and perfusion-based magnetic resonance imaging signatures and radio-pathomic maps of tumor pathology in a large, multi-site cohort.</p><p><strong>Methods: </strong>This study included perfusion imaging from presurgical relative cerebral blood volume (rCBV) images from the UPenn-GBM dataset and presurgical arterial spin labeling (ASL) imaging from the UCSF-PDGM dataset. Diffusion imaging included fractional anisotropy (FA) estimates derived from diffusion tensor imaging for each subject from each institution. A previously validated autopsy-based model was applied to the structural images from each patient to generate quantitative radio-pathomic maps of cell density and extracellular fluid (ECF). Mean cell density, ECF density, FA, rCBV calculated from dynamic susceptibility contrast imaging, and rCBF calculated from ASL were computed for each patient and statistically compared within contrast-enhancement (CE) and the non-enhancing peritumor FLAIR hyperintensity (FH).</p><p><strong>Results: </strong>Both rCBV and ASL showed a positive correlation with cell density within CE (rCBV: R = 0.280, P < .001; ASL: R = 0.117, P = .023). However, both perfusion metrics also showed no association with cell density within the FH region at the group level (rCBV: R = 0.0162, P = .731; ASL: R = -0.020, P = .652). Negative correlations were observed between FA and ECF density across both CE and FH in both the UPenn-GBM (CE: r = -.204, P < .001, FH: r = -.332, P < .001) and the UCSF-PDGM (CE:r = -.179, P < .001, FH:-0.355, P < .001). Additionally, a positive ASL-cell density association per subject within FH was associated with a worse survival prognosis (HR = 5.58, P = .022).</p><p><strong>Conclusions: </strong>These results suggest that radio-pathomic maps of tumor pathology provide complementary information to other MR signatures that reveal prognostically valuable signatures of the non-enhancing tumor margin.</p>","PeriodicalId":19377,"journal":{"name":"Neuro-oncology","volume":" ","pages":"1899-1909"},"PeriodicalIF":13.4000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12417833/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/neuonc/noaf044","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: This study determines the relationship between diffusion and perfusion-based magnetic resonance imaging signatures and radio-pathomic maps of tumor pathology in a large, multi-site cohort.

Methods: This study included perfusion imaging from presurgical relative cerebral blood volume (rCBV) images from the UPenn-GBM dataset and presurgical arterial spin labeling (ASL) imaging from the UCSF-PDGM dataset. Diffusion imaging included fractional anisotropy (FA) estimates derived from diffusion tensor imaging for each subject from each institution. A previously validated autopsy-based model was applied to the structural images from each patient to generate quantitative radio-pathomic maps of cell density and extracellular fluid (ECF). Mean cell density, ECF density, FA, rCBV calculated from dynamic susceptibility contrast imaging, and rCBF calculated from ASL were computed for each patient and statistically compared within contrast-enhancement (CE) and the non-enhancing peritumor FLAIR hyperintensity (FH).

Results: Both rCBV and ASL showed a positive correlation with cell density within CE (rCBV: R = 0.280, P < .001; ASL: R = 0.117, P = .023). However, both perfusion metrics also showed no association with cell density within the FH region at the group level (rCBV: R = 0.0162, P = .731; ASL: R = -0.020, P = .652). Negative correlations were observed between FA and ECF density across both CE and FH in both the UPenn-GBM (CE: r = -.204, P < .001, FH: r = -.332, P < .001) and the UCSF-PDGM (CE:r = -.179, P < .001, FH:-0.355, P < .001). Additionally, a positive ASL-cell density association per subject within FH was associated with a worse survival prognosis (HR = 5.58, P = .022).

Conclusions: These results suggest that radio-pathomic maps of tumor pathology provide complementary information to other MR signatures that reveal prognostically valuable signatures of the non-enhancing tumor margin.

放射病理图与胶质瘤特征相关的扩散和灌注MRI多位点回顾性分析。
简介:本研究确定了一个大型、多地点队列中基于扩散和灌注的MRI特征与肿瘤病理放射病理图之间的关系。方法:本研究包括来自UPenn-GBM数据集的术前相对脑血容量(rCBV)图像的灌注成像和来自UCSF-PDGM数据集的术前动脉自旋标记(ASL)成像。扩散成像包括来自每个机构的每个受试者的扩散张量成像(DTI)得出的分数各向异性(FA)估计。将先前验证的基于尸体解剖的模型应用于每位患者的结构图像,以生成细胞密度和细胞外液(ECF)的定量放射病理图。计算每位患者的平均细胞密度、ECF密度、FA、DSC成像计算的rCBV和ASL计算的rCBF,并在对比增强(CE)和非增强瘤周FLAIR高强度(FH)内进行统计学比较。结果:rCBV和ASL与CE内的细胞密度呈正相关(rCBV: R=0.280, p)。讨论:这些结果表明,肿瘤病理的放射病理图为其他MR特征提供了补充信息,这些特征揭示了非增强肿瘤边缘的预后价值特征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neuro-oncology
Neuro-oncology 医学-临床神经学
CiteScore
27.20
自引率
6.30%
发文量
1434
审稿时长
3-8 weeks
期刊介绍: Neuro-Oncology, the official journal of the Society for Neuro-Oncology, has been published monthly since January 2010. Affiliated with the Japan Society for Neuro-Oncology and the European Association of Neuro-Oncology, it is a global leader in the field. The journal is committed to swiftly disseminating high-quality information across all areas of neuro-oncology. It features peer-reviewed articles, reviews, symposia on various topics, abstracts from annual meetings, and updates from neuro-oncology societies worldwide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信